The message reads, in part:
“Today, it is precisely the large-scale introduction of advanced innovative technologies and the results of research projects in genetics, biology and other disciplines that determine the successful development of national and global pharmaceutical sectors, medicine and healthcare. It goes without saying that your company, which ensures the complete cycle of developing and manufacturing medication, including that based on the ready-made anti-bodies technology, for treating oncological, auto-immune and infectious diseases ranks among the recognised leaders and innovators in this sphere. Its exceptional efficiency makes this medication segment extremely popular, and it completely meets our domestic demand.
I would like, of course, to specially note your significant contribution to fighting the COVID-19 epidemic. During the complicated conditions of the pandemic, you managed to quickly launch and streamline the mass production of the Sputnik V vaccine. This tremendously difficult and intensive work is very important for protecting people’s lives and their health.
I am aware that you will have to implement many serious and large-scale projects. I sincerely wish that all of them succeed, and I wish you all the very best.”